Explore our Q3 2025 performance, including a 13.93% net return, driven by the AI boom and key tech holdings. Learn about our ...

Insight Molecular Diagnostics Inc. is rated Hold due to upcoming catalysts & pending FDA submission for GraftAssureDx. Read ...

Philip Petursson says strong earnings across sectors and moderating inflation support steady market gains heading into 2026.

We have some huge changes in our latest mock draft as we pass the midway point of the NFL season, including two quarterbacks in the top six picks who weren't even ranked at the start of the season.

Berkshire Hathaway is celebrated for long-term value growth under Warren Buffett's value investing strategy. Target offers a strong dividend yield and potential growth despite recent challenges, ...

China’s carbon dioxide (CO2) emissions were unchanged from a year earlier in the third quarter of 2025, extending a flat or falling trend that started in March 2024.

Stellix Capital Transaction -- In September, Team, Inc. completed a $75 million private placement of preferred stock and ...